-
2022-501361-44-00
Adult patients of either gender with active moderate to 5
-
2025-522076-85-00
Rheumatoid arthritis 4
-
2025-522471-28-00
psoriatic arthritis (PsA) 5
-
2025-522586-30-00
Psoriatic Arthritis 5
-
2025-520721-21-00
Rheumatoid Arthritis 4 2025-10-20
-
2025-523141-10-00
Active Psoriatic Arthritis 4 2026-03-20
-
2025-520831-18-00
Primary Sjogren’s Disease 4 2025-12-12
-
2024-518438-94-00
Heart failure 4 2025-10-24
-
2024-516652-18-00
Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
-
2024-519291-11-00
Psoriatic Arthritis 4 2025-07-25
-
2024-513111-27-00
Psoriatic Arthritis 5 2025-06-26
-
2023-506460-14-00
Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
-
2024-516219-25-00
psoriatic arthritis 5 2025-03-25
-
2023-508581-15-00
Heart condition 5 2024-10-08
-
2023-508162-15-00
Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
-
2025-520520-17-00
Heterozygous familial hypercholesterolaemia 5 2025-09-05
-
2025-520521-21-00
Hyperlipidemia 5 2025-09-02
-
2024-515973-82-00
ACPA-Positive Rheumatoid Arthritis 4 2025-06-23
-
2024-516213-20-00
Psoriatic arthritis 5 2025-03-25
-
2023-506457-38-00
Chronic kidney disease (CKD) and hypertension. 5 2024-06-05
-
2023-509320-17-00
non-radiographic axial spondyloarthritis 6 2023-03-28
-
2023-506256-25-00
Active Psoriatic Arthritis 5 2021-10-20
-
2024-510826-16-00
Rheumatoid Arthritis 5 2025-04-07
-
2023-506664-14-00
Rheumatoid Arthritis 5 2024-10-24